Skip to content

Vibrotactile Feedback Belt in Patients With Unilateral Vestibular Hypofunction (UVH)

Use of a Vibrotactile Feedback Belt in People With Chronic Disabling Unilateral Vestibular Hypofunction: a Single-case Experiment

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06300840
Acronym
VIBE
Enrollment
8
Registered
2024-03-08
Start date
2024-03-31
Completion date
2025-04-30
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Disorder

Keywords

vibrotactile feedback

Brief summary

The goal of this clinical trial is to study the impact of a continuous vibrotactile feedback belt on balance, (fear of) falling, fatigue and overall functioning in participants with chronic disabling unilateral vestibular hypofunction. The main questions it aims to answer are: • does wearing a vibrotactile feedback belt during waking hours for a week improve sense of balance and mobility, fear of falling, fatigue and overall functioning • does wearing a vibrotactile feedback belt influence static and dynamic balance and gait performance during balance and gait testing. Participants will goes through different phases in an randomized order; a baseline phase, a sham phase (i.e., wearing the BalanceBelt while it is switched off) and an intervention phase (i.e., wearing the BalanceBelt while it is switched on). It is expected that, just as with patients with bilateral loss of the balance organ, patients with a unilateral loss will also benefit from the BalanceBelt.

Interventions

The vibrotactile belt (i.e., Elitac BalanceBelt®) supports patients with severe balance disorders by substituting the missing balance information with vibrations (haptic feedback).

Sponsors

Hanna van Eijsden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Data-analyst and test-observer are masked

Intervention model description

Single-case-experiment (SCE) with a reversal design and with randomization of phases.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with severe unilateral vestibular dysfunction (i.e., a gain below 0.6 of the affected side and a gain between 0.8 and 1.1 of the contralateral side measured by the video-Head Impulse Test (vHIIT)). * Duration of dizziness complaints \>3 months (i.e. chronic dizziness). * Self-reported imbalance with a fear of falling and/or actual falls. * Is able to walk (with or without a walking aid). * Self-reported overall Mobility and Balance Score (MBS) of 3-5 points * Motivated to try the BalanceBelt. * Provides written informed consent.

Exclusion criteria

* Age \< 18 years * Presence of neurological, psychiatric or orthopaedic disorders, Persistent postural-perceptual dizziness (PPPD), reduced proprioceptive sensitivity or impaired vision which influences the postural stability. * Not able to understand instructions and questionnaires in Dutch * Not able/willing to visit Gelre Hospital Apeldoorn for necessary visits. * Wheelchair bound at home

Design outcomes

Primary

MeasureTime frameDescription
Mobility and Balance Score (MBS)Daily for 7 weeksThe MBS is a rating given by the patient on a scale ranging from 0 to 10, as a subjective grading of his or her overall mobility and balance in daily life. Where a higher score means a better score.

Secondary

MeasureTime frameDescription
Fear of fallingDaily for 7 weeksNumeric rating scale, rang 0-10, where a higher score means a better outcome.
fallsDaily for 7 weeksnumber of actual falls and near falls
structured interview on compliance on wearing the Balancebelt(R)Daily for 7 weekscompliance on wearing the Balancebelt(R)
Questionnaire: vestibular activity avoiding instrument (VAAI)At baseline and at the end of the study (8 weeks)vestibular activity avoiding instrument, score range 0-54, higher score means worse outcome.
Questionnaire: Dizziness handicap inventory (DHI)At baseline and at the end of the study (8 weeks)Dizziness handicap inventory, score range 0-100, higher score means worse outcome.
modified Clinical Test of Sensory Interaction on Balance (mCTSIB)At baseline and at the end of the study (8 weeks)modified Clinical Test of Sensory Interaction on Balance
Dynamic Gait Index (DGI)At the baseline and at the end of the study (8 weeks)Dynamic Gait Index, score 0-24, higher score means better outcome
Timed up and Go test (TUG)At baseline and at the end of the study (8 weeks)Timed up and Go test
General functioningDaily for 7 weeksNumeric rating scale (NRS), rang 0-10, where a higher score means a better outcome.
physical activity_NRSDaily for 7 weeksNumeric rating scale, rang 0-10, where a higher score means a better outcome.
physical activity_stepsDaily for 7 weeksNumber of steps a day
fatigueDaily for 7 weeksNumeric rating scale, rang 0-10, where a higher score means a better outcome.

Other

MeasureTime frameDescription
cause of vestibular hypofunctionBaselineetiology
Structured interview on vestibular rehabilitationBaselineprevious experience with vestibular rehabilitation (types of intervention, number of therapie sessions, benefit)
outcome of the vestibular function testsBaselineresults of available video-Head Impulse Test (vHIT) or caloric testing
Structured interview on participating in the researchAt the end of the study (8 weeks)experience of the research
Structured interview on the overall experience with the Balancebelt(R)At the end of the study (8 weeks)evaluation of the Balancebelt(R)
time since onset of the vestibular hypofunctionBaselinein months or years
ageBaselinein years

Countries

Netherlands

Contacts

Primary ContactHanna Koppelaar - van Eijsden, MSc
h.van.eijsden@gelre.nl+31555818470
Backup ContactTjard Schermer, PhD
t.schermer@gelre.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026